NASDAQ

Liminatus Pharma, Inc. - Class A (LIMN)

360 Thanks from members

Liminatus Pharma, Inc. Class A (LIMN) experiences extreme volatility trading near the $0.11–$0.14 range while actively appealing a Nasdaq delisting notice due to low market value, resulting in highly speculative market sentiment.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →